MENU

 Education

School ¡X Major ¡X Degree Duration

°ª¶¯Âå¾Ç¤j¾Ç ¡X Âå¾Ç¬ã¨s©Ò(²¦) ¡X ºÓ¤h

Master,  ,  

1998/09 ¡X 2003/06

°ª¶¯Âå¾Ç°| ¡X Âå¾Ç¨t(²¦) ¡X ¾Ç¤h

Bachelor,  ,  

1985/09 ¡X 1992/06

 Intramural Experience

Office/Department/Institute Position Duration
­G¸z¤º¬ì Division of Gastroenterology   Visiting Staff   ¡X  
¤º¬ì¾Ç¬ì Department of Internal Medicine   Professor 2019/08/01 ¡X  
¤º¬ì¾Ç¬ì Department of Internal Medicine   Associate Professor 2014/08/01 ¡X 2019/07/31
¤º¬ì¾Ç¬ì Department of Internal Medicine   Assistant Professor 2008/08/01 ¡X 2014/07/31

 Extramural Experience

 

 Discipline

 

 Research & Technology Platform Open to the Outside

 

 Interested Area(s)for Interdisciplinary Research

·L¥Íª«¤Î§K¬Ì¾Ç¬ì¡BÃIJz¾Ç¬ì¡B¤½¦@½Ã¥Í¤ÎÀô¹ÒÂå¾Ç¡BÂå¾Ç¤§¥Í¤Æ¤Î¤À¤l¥Íª«¡B®a®xÂå¾Ç¬ì¡B¥Í²z¾Ç¬ì

 

 Area(s) of Expertise & Research

®ø¤Æ¨t¤º¬ì¡B«ÕªùÁ³±Û±ìµß¡B­G¸z¹D¯e¯f¡B¤À¤l¥Íª«¾Ç

 

 Publication

NO Publication
1

Machine learning models for screening clinically significant nephrolithiasis in overweight and obese populations.
³¯¯EÞ³, §õ®e´@, ÃQ°ö­×, ³¯§±ºÂ, §d¬F¼Ý, ªL¹Å¯q, ©P¥H©M, §d¤å¥¿, °ª±R³ó* - - 1 - WORLD JOURNAL OF UROLOGY - WORLD JOURNAL OF UROLOGY 2024 42¨÷(1´Á):128­¶
(IF: 2.8, »â°ì±Æ¦W: 33, »â°ì´Á¥Z¼Æ: 126, »â°ì±Æ¦W: 26.19%)

Machine learning models for screening clinically significant nephrolithiasis in overweight and obese populations.
Hao-Wei Chen, Jung-Ting Lee, Pei-Siou Wei, Yu-Chen Chen, Jeng-Yih Wu, Chia-I Lin, Yii-Her Chou, Yung-Shun Juan, Wen-Jeng Wu, Chung-Yao Kao - - 1 - WORLD JOURNAL OF UROLOGY - WORLD JOURNAL OF UROLOGY 2024;42(1):128
(IF: 2.8, Journal Ranking: 33, Number of Journals of this Field: 126, Ranking: 26.19%)

2

Exhaled Hydrogen after Lactulose Hydrogen Breath Test in Patient with Duodenal Ulcer Disease-A Pilot Study for -Associated Gastroduodenal Disease.
³¯¥H¾±,³¯¨Î¦p,¤ý«T°¶,¼B´º¾±,§d¬F¼Ý,§dµn±j, Ĭ¨|¥¿* - - 1 - LIFE (BASEL, SWITZERLAND) - LIFE-BASEL 2023 13¨÷(1´Á):45­¶
(IF: 3.253, »â°ì±Æ¦W: 39, »â°ì´Á¥Z¼Æ: 94, »â°ì±Æ¦W: 41.49%)

Exhaled Hydrogen after Lactulose Hydrogen Breath Test in Patient with Duodenal Ulcer Disease-A Pilot Study for -Associated Gastroduodenal Disease.
Yi-Hsun Chen, Sharon Chia-Ju Chen, Jiunn-Wei Wang, Chiang-Shin Liu, Jeng-Yih Wu, Deng-Chyang Wu, Yu-Chung Su - - 1 - LIFE (BASEL, SWITZERLAND) - LIFE-BASEL 2023;13(1):45
(IF: 3.253, Journal Ranking: 39, Number of Journals of this Field: 94, Ranking: 41.49%)

3

Eradicating via C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
¹p°¶¶h, Jian-Yu Lee, Shu-Ling Chuang, ¥Õ©ú©¾, ³¯°·Åï, §d¬F¼Ý, §dµn±j, Felice Tien O'Donnell, Hui-Wen Tien, Yi-Ru Chen, Tsung-Hsien Chiang, Yu-Hsin Hsu, Tsui-Hsia Hsu, Pei-Chun Hsieh, Li-Ju Lin, Shu-Li Chia, Chao-Chun Wu, Yi-Maun Subeq, Shu-Hui Wen, Hsiu-Chun Chang, Yu-Wen Lin, Kuo-Ping Sun, ¦¶®a²», §d©ú½å, David Y Graham, ³¯¨qº³, §õ©y®a* - - 1 - GUT - GUT 2023 72¨÷(12´Á):2231-2240­¶
(IF: 24.5, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 5.38%)

Eradicating via C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
Wei-Yi Lei, Jian-Yu Lee, Shu-Ling Chuang, Ming-Jong Bair, Chien-Lin Chen, Jeng-Yih Wu, Deng-Chyang Wu, Felice Tien O'Donnell, Hui-Wen Tien, Yi-Ru Chen, Tsung-Hsien Chiang, Yu-Hsin Hsu, Tsui-Hsia Hsu, Pei-Chun Hsieh, Li-Ju Lin, Shu-Li Chia, Chao-Chun Wu, Yi-Maun Subeq, Shu-Hui Wen, Hsiu-Chun Chang, Yu-Wen Lin, Kuo-Ping Sun, Chia-Hsiang Chu, Ming-Shiang Wu, David Y Graham, Hsiu-Hsi Chen, Yi-Chia Lee - - 1 - GUT - GUT 2023;72(12):2231-2240
(IF: 24.5, Journal Ranking: 5, Number of Journals of this Field: 93, Ranking: 5.38%)

4

Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial.
Á©s®Ñ, ³¢´I¬Ã, §d©sªN, ¤ý«T°¶, ¼B©¾ºa, ¦¶¯à¥Í, ½²¯\ªå, ³\ªÃ¼Ý, §d©y¬Ã, §d¬F¼Ý, §dµn±j, §E¤èºa*, ³¢¬L§»* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION = TAIWAN YI ZHI - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2022 121¨÷(8´Á):1450-1457­¶
(IF: 3.871, »â°ì±Æ¦W: 61, »â°ì´Á¥Z¼Æ: 172, »â°ì±Æ¦W: 35.47%)

Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial.
Meng-Shu Hsieh, Fu-Chen Kuo, Meng-Chieh Wu, Jiunn-Wei Wang, Chung-Jung Liu, Neng-Sheng Chu, Pei-Yun Tsai, Ping-I Hsu, I-Chen Wu, Jeng-Yih Wu, Deng-Chyang Wu, Fang-Jung Yu, Chao-Hung Kuo - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION = TAIWAN YI ZHI - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2022;121(8):1450-1457
(IF: 3.871, Journal Ranking: 61, Number of Journals of this Field: 172, Ranking: 35.47%)

5

Comparison of Endoscopic Submucosal Dissection Application on Mucosal Tumor and Subepithelial Tumor in stomach
³\¤åÂE,§d©v¾±,Á©s®Ñ,ÅǨ|¥Á,¤ýÄ£¼s,§d¬F¼Ý,§E¤èºa,³¢¬L§»,Ĭ¨|¥¿,¤ý·Ó¤¸,§dµn±j,­J®Ì»ï* - - 1 - J Cancer - EUROPEAN JOURNAL OF CANCER CARE 2021 12¨÷(3´Á):765-770­¶
(IF: 2.52, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 122, »â°ì±Æ¦W: 18.85%)

Comparison of Endoscopic Submucosal Dissection Application on Mucosal Tumor and Subepithelial Tumor in stomach
Wen-Hung Hsu, Tzung-Shiun Wu, Meng-Shu Hsieh, Yu-Min Kung, Yao-Kuang Wang, Jeng-Yih Wu, Fang-Jung Yu, Chao-Hung Kuo, Yu-Chung Su, Jaw-Yuan Wang, Deng-Chyang Wu, Huang-Ming Hu - - 1 - J Cancer - EUROPEAN JOURNAL OF CANCER CARE 2021;12(3):765-770
(IF: 2.52, Journal Ranking: 23, Number of Journals of this Field: 122, Ranking: 18.85%)

6

Gastroduodenal intussusception caused by gastric gastrointestinal stromal tumor: A case report and review of the literature.
Á©ö­Û,³\¤åÂE,§õ¨ÊëÞ,§d«TªN,§dµn±j,§d¬F¼Ý* - - 1 - WORLD JOURNAL OF CLINICAL CASES - WORLD JOURNAL OF CLINICAL CASES 2021 9¨÷(4´Á):838-846­¶
(IF: 1.013, »â°ì±Æ¦W: 120, »â°ì´Á¥Z¼Æ: 165, »â°ì±Æ¦W: 72.73%)

Gastroduodenal intussusception caused by gastric gastrointestinal stromal tumor: A case report and review of the literature.
Yi-Lun Hsieh,Wen-Hung Hsu,Ching-Chun Lee,Chun-Chieh Wu,Deng-Chyang Wu,Jeng-Yih Wu - - 1 - WORLD JOURNAL OF CLINICAL CASES - WORLD JOURNAL OF CLINICAL CASES 2021;9(4):838-846
(IF: 1.013, Journal Ranking: 120, Number of Journals of this Field: 165, Ranking: 72.73%)

7

Proactive measures for the pandemic COVID-19 infection in outpatient clinics of Otolaryngology Department
²ºÕ¦ö, §d¬F¼Ý, ¤ý­â®p* - - 1 - Kaohsiung Journal of Medical Sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020 36¨÷(6´Á):473-474­¶
(IF: 1.737, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 138, »â°ì±Æ¦W: 77.54%)

Proactive measures for the pandemic COVID-19 infection in outpatient clinics of Otolaryngology Department
Chen-Yu Chien, Jeng-Yih Wu, Ling-Feng Wang* - - 1 - Kaohsiung Journal of Medical Sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020;36(6):473-474
(IF: 1.737, Journal Ranking: 107, Number of Journals of this Field: 138, Ranking: 77.54%)

8

­G­¹ºÞ¤Ï¬y¯f¤¤­G±ÆªÅ½wºCªº¹w´ú¦]¯À
¤ý«a¤¸,³¯·¶¶²,¤ý«º¤D,³\¤åÂE,§d©y¬Ã,§E¤èºa,­J®Ì»ï,§d¬F¼Ý,³¢¬L§»,¿c«Ø¦t,§dµn±j,Ĭ¨|¥¿* - - 1 - J Gastroenterol Hepatol - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2019 34¨÷(5´Á):837-842­¶
(IF: 3.632, »â°ì±Æ¦W: 30, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 35.71%)

Predictor of slower gastric emptying in gastroesophageal reflux disease: Survey of an Asian-Pacific cohort
Wang KY, Chen YW, Wang TN, Hsu WH, Wu IC, Yu FJ, Hu HM, Wu JY, Kuo CH, Lu CY, Wu DC, Su YC* - - 1 - J Gastroenterol Hepatol - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2019;34(5):837-842
(IF: 3.632, Journal Ranking: 30, Number of Journals of this Field: 84, Ranking: 35.71%)

9

The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal
§d¬F¼Ý,§õ©y®a, Graham DY* - - 1 - Expert Rev Gastroenterol Hepatol - EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 2019 13¨÷(1´Á):17-24­¶
(IF: 2.991, »â°ì±Æ¦W: 46, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 54.76%)

The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal
Wu JY, Lee YC, Graham DY* - - 1 - Expert Rev Gastroenterol Hepatol - EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 2019;13(1):17-24
(IF: 2.991, Journal Ranking: 46, Number of Journals of this Field: 84, Ranking: 54.76%)

10

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
¼B§Ó»Ê, ³¯¤¶³¹, Chang CM, ¤è¥»µü, ¥Õ©ú©¾, ³¯¬f©¨, ±i¦N¥õ, ³\Ä£«T, ³¯¬ü§Ó,³¯«Ø¥þ, Lee JY, Yang TH,ù´º¥þ, Chen CY, ³\¤å®p, ³¯«Û¦~, §d¬F¼Ý, ªL»F°ó, Lu TP, Chuang EY, El-Omar EM, §d©ú½å* - - 1 - Lancet Infect Dis - LANCET INFECTIOUS DISEASES 2019 19¨÷(10´Á):1109-1120­¶
(IF: 27.516, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 89, »â°ì±Æ¦W: 1.12%)

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
Liou JM, Chen CC, Chang CM, Fang YJ, Bair MJ, Chen PY, Chang CY, Hsu YC, Chen MJ, Chen CC, Lee JY, Yang TH, Luo JC, Chen CY, Hsu WF, Chen YN, Wu JY, Lin JT, Lu TP, Chuang EY, El-Omar EM, Wu MS* - - 1 - Lancet Infect Dis - LANCET INFECTIOUS DISEASES 2019;19(10):1109-1120
(IF: 27.516, Journal Ranking: 1, Number of Journals of this Field: 89, Ranking: 1.12%)

11

Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo
Guan SS, Wu CT, Chiu CY, Luo TY, §d¬F¼Ý, Liao TZ, Liu SH. - - 1 - J Transl Med - JOURNAL OF TRANSLATIONAL MEDICINE 2018 16¨÷(1´Á):168­¶
(IF: 4.197, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 133, »â°ì±Æ¦W: 21.05%)

Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo
Guan SS, Wu CT, Chiu CY, Luo TY, Wu JY, Liao TZ, Liu SH. - - 1 - J Transl Med - JOURNAL OF TRANSLATIONAL MEDICINE 2018;16(1):168
(IF: 4.197, Journal Ranking: 28, Number of Journals of this Field: 133, Ranking: 21.05%)

12

The role of integrating conjugative elements in Helicobacter pylori: a review
Waskito LA, §d¬F¼Ý, Yamaoka Y* - - 1 - J Biomed Sci - JOURNAL OF BIOMEDICAL SCIENCE 2018 25¨÷(1´Á):86­¶
(IF: 3.466, »â°ì±Æ¦W: 46, »â°ì´Á¥Z¼Æ: 133, »â°ì±Æ¦W: 34.59%)

The role of integrating conjugative elements in Helicobacter pylori: a review
Waskito LA, Wu JY, Yamaoka Y - - 1 - J Biomed Sci - JOURNAL OF BIOMEDICAL SCIENCE 2018;25(1):86
(IF: 3.466, Journal Ranking: 46, Number of Journals of this Field: 133, Ranking: 34.59%)

13

·í²Ä¤@½uÀøªkªvÀøÂಾ©Ê¤j¸zª½¸zÀù¦X¨ÖÄY­«¶À¯nªº¯f¤H
¶À·q¤å,¸­¥ÃªQ,°¨¬F¤¯, ¶ÀÌÅ»ö, ¿c«Ø¦t, §d¬F¼Ý,¤ý·Ó¤¸* - - 1 - CHEMOTHERAPY - CHEMOTHERAPY 2017 62¨÷(1´Á):80-84­¶
(IF: 0.843, »â°ì±Æ¦W: 230, »â°ì´Á¥Z¼Æ: 256, »â°ì±Æ¦W: 89.84%)

Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as a First-Line Treatment.
Huang CW, Yeh YS, Ma CJ, Tsai HL, Chen CW, Huang MY, Lu CY, Wu JY, Wang JY* - - 1 - CHEMOTHERAPY - CHEMOTHERAPY 2017;62(1):80-84
(IF: 0.843, Journal Ranking: 230, Number of Journals of this Field: 256, Ranking: 89.84%)

14

²Ä¤T´Á¤j¸zÀù¯f±w±µ¨ü®Úªv¤â³N«á±µ¨üFOLFOX4»²§U¤ÆÀø©Î±µ¨üFOLFOX4¥[¤fªAUFUR/LV»²§U¤ÆÀøªº¤ñ¸û
¶ÀÌÅ»ö,¶À¶v¥Á,½²²»Åï,¶À·q¤å,Á¼z±Ó,¸­¥ÃªQ,§d¬F¼Ý,¤ý¤å©ú,¤ý·Ó¤¸* - - 1 - Oncology Letters - Oncol Lett 2017 14¨÷(6´Á):6754-6762­¶
(IF: 1.39, »â°ì±Æ¦W: 192, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 88.48%)

Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection
Ming-Yii Huang,Chun-Ming Huang,Hsiang-Lin Tsai,Ching-Wen Huang,Hui-Min Hsieh,Yung-Sung Yeh,Jeng-Yih Wu,Wen-Ming Wang, Jaw-Yuan Wang* - - 1 - Oncology Letters - Oncol Lett 2017;14(6):6754-6762
(IF: 1.39, Journal Ranking: 192, Number of Journals of this Field: 217, Ranking: 88.48%)

15

Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
Kuo YT, ¼B§Ó»Ê, El-Omar EM, §d¬F¼Ý, Leow AHR, Goh KL, Das R, Lu H, Lin JT, Tu YK, Yamaoka Y*,§d©ú½å*; Asian Pacific Alliance on Helicobacter and Microbiota - - 9 - Lancet Gastroenterol Hepatol - Lancet Gastroenterol Hepatol 2017 2¨÷(10´Á):707-715­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
Kuo YT, Liou JM, El-Omar EM, Wu JY, Leow AHR, Goh KL, Das R, Lu H, Lin JT, Tu YK, Yamaoka Y*, Wu MS*; Asian Pacific Alliance on Helicobacter and Microbiota - - 9 - Lancet Gastroenterol Hepatol - Lancet Gastroenterol Hepatol 2017;2(10):707-715
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

16

Systematic review with meta-analysis: 10-or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
Liou JM, Chen CC, Lee YC, Chang CY,§d¬F¼Ý, Bair MJ, Lin JT, Chen MJ, Wu MS*; Taiwan Gastrointestinal Disease and Helicobacter Consortium. - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENT PHARM THER 2016 43¨÷(4´Á):470-481­¶
(IF: 6.32, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 255, »â°ì±Æ¦W: 4.71%)

Systematic review with meta-analysis: 10-or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
Liou JM, Chen CC, Lee YC, Chang CY, Wu JY, Bair MJ, Lin JT, Chen MJ, Wu MS*; Taiwan Gastrointestinal Disease and Helicobacter Consortium. - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENT PHARM THER 2016;43(4):470-481
(IF: 6.32, Journal Ranking: 12, Number of Journals of this Field: 255, Ranking: 4.71%)

17

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM, Fang YJ, Chen CC, Bair MJ, Chang CY, Lee YC, Chen MJ, Chen CC, Tseng CH, Hsu YC, Lee JY, Yang TH, Luo JC, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hu WH, Chen YN, Sheu BS, Lin JT,§d¬F¼Ý*, El-Omar EM, Wu MS* - - 1 - LANCET - LANCET 2016 388¨÷(10058´Á):2355-2365­¶
(IF: 44.002, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 1.29%)

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM, Fang YJ, Chen CC, Bair MJ, Chang CY, Lee YC, Chen MJ, Chen CC, Tseng CH, Hsu YC, Lee JY, Yang TH2, Luo JC, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hu WH, Chen YN, Sheu BS, Lin JT, Wu JY*, El-Omar EM, Wu MS - - 1 - LANCET - LANCET 2016;388(10058):2355-2365
(IF: 44.002, Journal Ranking: 2, Number of Journals of this Field: 155, Ranking: 1.29%)

18

Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial
¼B§Ó»Ê,¥Õ©ú©¾,³¯¤¶³¹,§õ©y®a,³¯¬ü§Ó,³¯«Ø¥þ,´¿¬F»¨,¤è¯§¤¯,§õ°ò¸Î,·¨©v¾ì,ù´º¥þ,§d¬F¼Ý,±i¤åºµ,±i§g·Ó,³¯±Ò¯q,³¯¬f©¨,®]®a´É,³\¤å®p,Hung HW,ªL»F°ó,±i¦N¥õ*,§d©ú½å* - - 1 - AMERICAN JOURNAL OF GASTROENTEROLOGY - Am J Gastroenterol 2016 111¨÷(3´Á):381-7­¶
(IF: 10.383, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 7.59%)

Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial
Liou JM, Bair MJ, Chen CC, Lee YC, Chen MJ, Chen CC, Tseng CH, Fang YJ, Lee JY, Yang TH, Luo JC, Wu JY, Chang WH, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hung HW, Lin JT, Chang CY*, Wu MS* - - 1 - AMERICAN JOURNAL OF GASTROENTEROLOGY - Am J Gastroenterol 2016;111(3):381-7
(IF: 10.383, Journal Ranking: 6, Number of Journals of this Field: 79, Ranking: 7.59%)

19

Chemokine (C-C motif) ligand 5 is involved in tumor-associated dendritic cell-mediated colon cancer progression through non-coding RNA MALAT-1.
¥Ì»T·ì,§dµn±j,§EªÚºa,§d¬F¿o,²²QªÚ,¬x¤¯¦t,¤ý·Ó¤¸*,³¢¬fÅï* - - 1 - JOURNAL OF CELLULAR PHYSIOLOGY - J CELL PHYSIOL 2015 230¨÷(8´Á):1883-1894­¶
(IF: 3.839, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 83, »â°ì±Æ¦W: 18.07%)

Chemokine (C-C motif) ligand 5 is involved in tumor-associated dendritic cell-mediated colon cancer progression through non-coding RNA MALAT-1.
Kan JY, Wu DC, Yu FJ, Wu CY, Ho YW, Chiu YJ, Jian SF, Hung JY, Wang JY*, Kuo PL*. - - 1 - JOURNAL OF CELLULAR PHYSIOLOGY - J CELL PHYSIOL 2015;230(8):1883-1894
(IF: 3.839, Journal Ranking: 15, Number of Journals of this Field: 83, Ranking: 18.07%)

20

Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patients.
½²²»Åï,ªL´¼ÂE,¶À·q¤å,·¨¥H«Ì,¸­¥ÃªQ,³\¤åÂE,§d¬F¼Ý,³¢¬L§»,Tseng FY*,¤ý·Ó¤¸* - - 1 - International Journal of Clinical and Experimental Pathology - INT J CLIN EXP PATHO 2015 8¨÷(2´Á):1900-1910­¶
(IF: 1.891, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 52.63%)

Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patients.
Tsai HL,Lin CH,Huang CW,Yang IP,Yeh YS,Hsu WH,Wu JY,Kuo CH,Tseng FY,Wang JY. - - 1 - International Journal of Clinical and Experimental Pathology - INT J CLIN EXP PATHO 2015;8(2):1900-1910
(IF: 1.891, Journal Ranking: 40, Number of Journals of this Field: 76, Ranking: 52.63%)

21

Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
Yu-Jen Fang, ¼B§Ó»Ê*, ³¯¤¶³¹, Ji-Yuh Lee, Yao-Chun Hsu, Mei-Jyh Chen2, Ping-Huei Tseng, Chien-Chuan Chen, Chi-Yang Chang, Tsung-Hua Yang, ±i¤åºµ, §d¬F¼Ý, ¤ý¨q§B, ù´º¥þ, ªL»F°ó, ®]®a´É, §d©ú½å* - - 1 - GUT - GUT 2015 64¨÷(10´Á):1517-1528­¶
(IF: 14.66, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 2.63%)

Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
Fang YJ, Liou JM, Chen CC, Lee JY, Hsu YC, Chen MJ, Tseng PH, Chen CC, Chang CY, Yang TH1, Chang WH5, Wu JY6, Wang HP2, Luo JC7, Lin JT8, Shun CT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium - - 1 - GUT - GUT 2015;64(10):1517-1528
(IF: 14.66, Journal Ranking: 2, Number of Journals of this Field: 76, Ranking: 2.63%)

22

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study
¼B§Ó»Ê, ±i¦N¥õ, ³¯¬ü§Ó, ³¯¤¶³¹, Yu-Jen Fang, Ji-Yuh Lee, §d¬F¼Ý, ù´º¥þ, ¼B®õ¦¨, ±i¤åºµ, ´¿¬F»¨, §d«T¿o, Tsung-Hua Yang, ±i§g·Ó, ¤ý¨q§B, ³\³Õµ¾, ªL»F°ó, ¥Õ©ú©¾, §d©ú½å*, Taiwan Gastrointestinal Disease and Helicobacter Consortium - - 1 - PLoS One - PLOS ONE 2015 10¨÷(5´Á):e0124199­¶
(IF: 3.234, »â°ì±Æ¦W: 9, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 15.79%)

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study
Liou JM, Chang CY, Chen MJ, Chen CC, Fang YJ, Lee JY, Wu JY, Luo JC, Liou TC, Chang WH, Tseng CH, Wu CY, Yang TH, Chang CC, Wang HP, Sheu BS, Lin JT, Bair MJ, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium - - 1 - PLoS One - PLOS ONE 2015;10(5):e0124199
(IF: 3.234, Journal Ranking: 9, Number of Journals of this Field: 57, Ranking: 15.79%)

23

Diagnosis of Helicobacter pylori infection: Current options and developments
¤ýÄ£¼s,³¢´I¬Ã,¼B©¾ºa,§d©sªN,¬Iµ¾Ä£,¤ý¸t¶², §d¬F¼Ý,³¢¬L§»,¶ÀÄ£±d*,§dµn±j* - - 1 - WORLD JOURNAL OF GASTROENTEROLOGY - WORLD J GASTROENTERO 2015 21¨÷(40´Á):11221-11235­¶
(IF: 2.369, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 53.95%)

Diagnosis of Helicobacter pylori infection: Current options and developments
Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, Wu JY, Kuo CH, Huang YK*, Wu DC* - - 1 - WORLD JOURNAL OF GASTROENTEROLOGY - WORLD J GASTROENTERO 2015;21(40):11221-11235
(IF: 2.369, Journal Ranking: 41, Number of Journals of this Field: 76, Ranking: 53.95%)

24

Propofol target-controlled infusion for sedated gastrointestinal endoscopy: A comparison of propofol alone versus propofol-fentanyl-midazolam.
³\㤦, Huang JM, Chuang YP, Wei HY, Su YC,§d¬F¼Ý,¤ý¤å©ú, ³\¥°¼w,¶À´fªÚ, ¿c«³¥à, ¿c°¶*. - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2015 31¨÷(11´Á):580-584­¶
(IF: 0.803, »â°ì±Æ¦W: 104, »â°ì´Á¥Z¼Æ: 124, »â°ì±Æ¦W: 83.87%)

Propofol target-controlled infusion for sedated gastrointestinal endoscopy: A comparison of propofol alone versus propofol-fentanyl-midazolam.
Hsu CD, Huang JM, Chuang YP, Wei HY, Su YC, Wu JY, Wang WM, Hsu HT, Huang HF, Lu IC, Lu DV*. - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2015;31(11):580-584
(IF: 0.803, Journal Ranking: 104, Number of Journals of this Field: 124, Ranking: 83.87%)

25

Evidence-based recommendations for successful Helicobacter pylori treatment
§d¬F¼Ý,¼B§Ó»Ê(¦@¦P²Ä¤@),Graham DY* - - 1 - Expert Review of Gastroenterology & Hepatology - EXPERT REV GASTROENT 2014 8¨÷(1´Á):21-28­¶
(IF: 2.546, »â°ì±Æ¦W: 33, »â°ì´Á¥Z¼Æ: 75, »â°ì±Æ¦W: 44.00%)

Evidence-based recommendations for successful Helicobacter pylori treatment
Wu JY, Liou JM, Graham DY* - - 1 - Expert Review of Gastroenterology & Hepatology - EXPERT REV GASTROENT 2014;8(1):21-28
(IF: 2.546, Journal Ranking: 33, Number of Journals of this Field: 75, Ranking: 44.00%)

26

Discovery of tumor markers for gastric cancer by proteomics
§d¬F¼Ý, µ{«T¹Å, ¤ý·Ó¤¸, §dµn±j, Á«ؾ±, §õ·ç¦¨, ¤ý¤å©ú* - - 1 - PLoS One - PLoS One 2014 9¨÷(1´Á):e84158(1-7)­¶
(IF: 3.534, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 14.55%)

Discovery of tumor markers for gastric cancer by proteomics
Wu JY, Cheng CC, Wang JY, Wu DC, Hsieh JS, Lee SC, Wang WM* - - 1 - PLoS One - PLoS One 2014;9(1):e84158(1-7)
(IF: 3.534, Journal Ranking: 8, Number of Journals of this Field: 55, Ranking: 14.55%)

27

Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests
§d¬F¼Ý, ¤ý¸t¶², §õ©ö¿Û, Yamaoka Y, Graham DY, ¸â©÷©ú, ¤ý¤å©ú, §dµn±j* - - 1 - WORLD JOURNAL OF GASTROENTEROLOGY - WORLD J GASTROENTERO 2014 20¨÷(12´Á):3343-3349­¶
(IF: 2.433, »â°ì±Æ¦W: 36, »â°ì´Á¥Z¼Æ: 75, »â°ì±Æ¦W: 48.00%)

Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests
Wu JY, Wang SS, Lee YC, Yamaoka Y, Graham DY, Jan CM, Wang WM, Wu DC* - - 1 - WORLD JOURNAL OF GASTROENTEROLOGY - WORLD J GASTROENTERO 2014;20(12):3343-3349
(IF: 2.433, Journal Ranking: 36, Number of Journals of this Field: 75, Ranking: 48.00%)

28

Feasibility of Shortening 14-day Hybrid Therapy While Maintaining an Excellent Helicobacter pylori Eradication Rate
§d¬F¼Ý*, ³\ªÃ¼Ý, §dµn±j, Graham DY, ¤ý¤å©ú - - 1 - Helicobacter - Helicobacter 2014 19¨÷(3´Á):207-213­¶
(IF: 2.993, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 119, »â°ì±Æ¦W: 34.45%)

Feasibility of Shortening 14-day Hybrid Therapy While Maintaining an Excellent Helicobacter pylori Eradication Rate
Wu JY*, Hsu PI, Wu DC, Graham DY, Wang WM - - 1 - Helicobacter - Helicobacter 2014;19(3):207-213
(IF: 2.993, Journal Ranking: 41, Number of Journals of this Field: 119, Ranking: 34.45%)

29

Stromal cells induce Th17 during Helicobacter pylori infection and in the gastric tumor microenvironment.
Pinchuk IV, Morris KT, Nofchissey RA, Earley RB, §d¬F¼Ý, Ma TY, Beswick EJ* - - 1 - PLoS One - PLOS ONE 2013 8¨÷(1´Á):e53798­¶
(IF: 3.73, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 56, »â°ì±Æ¦W: 12.50%)

Stromal cells induce Th17 during Helicobacter pylori infection and in the gastric tumor microenvironment.
Pinchuk IV, Morris KT, Nofchissey RA, Earley RB, Wu JY, Ma TY, Beswick EJ* - - 1 - PLoS One - PLOS ONE 2013;8(1):e53798
(IF: 3.73, Journal Ranking: 7, Number of Journals of this Field: 56, Ranking: 12.50%)

30

Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?
³\ªÃ¼Ý*,§dµn±j,§d¬F¼Ý,Graham DY. - - 1 - Helicobacter. - HELICOBACTER 2011 16¨÷(2´Á):146-52­¶
(IF: 3.109, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 29.58%)

Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?
Hsu PI, Wu DC, Wu JY, Graham DY. - - 1 - Helicobacter. - HELICOBACTER 2011;16(2):146-52
(IF: 3.109, Journal Ranking: 21, Number of Journals of this Field: 71, Ranking: 29.58%)

31

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.
³\ªÃ¼Ý*,§dµn±j,§d¬F¼Ý,Graham DY. - - 1 - Helicobacter - HELICOBACTER 2011 16¨÷(2´Á):139-45­¶
(IF: 3.109, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 29.58%)

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.
Hsu PI, Wu DC, Wu JY, Graham DY. - - 1 - Helicobacter - HELICOBACTER 2011;16(2):139-45
(IF: 3.109, Journal Ranking: 21, Number of Journals of this Field: 71, Ranking: 29.58%)

32

«á¸¡µÄ¥¨¤j³æ¤@ÅÖºû½F
°ª²z¶v, ¶ÀÚ{´@, ½²²»Åï, Ĭ¨|¥¿, §d¬F¼Ý, ¤ý·Ó¤¸* - - 0 - Genomic Medicine, Biomarkers, and Health Sciences - 2011 3¨÷(2´Á):86-89­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

A huge retroperitoneal solitary fibrous tumor
Li-Chun Kao, Wan-Ting Huang, Hsiang-Lin Tsai, Yu-Chung Su, Jeng-Yih Wu, Jaw-Yuan Wang* - - 0 - Genomic Medicine, Biomarkers, and Health Sciences - 2011;3(2):86-89
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

33

Sequential and Concomitant Therapy with 4 drugs are Equally Effective for Eradication of H. pylori Infection
§dµn±j,³\ªÃ¼Ý,§d¬F¼Ý, Antoner. Opekun,³¢¬L§»,§d©y¬Ã,¤ý¸t¶²,³¯©M·æ,¬x¤å«T, David Y. Graham* - - 1 - Clin Gastroenterol Hepatol - CLIN GASTROENTEROL H 2010 8¨÷(1´Á):36-41­¶
(IF: 6.068, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 14.55%)

Sequential and Concomitant Therapy with 4 drugs are Equally Effective for Eradication of H. pylori Infection
Deng-Chyang Wu, Ping-I Hsu, Jeng-Yih Wu, Antoner. Opekun, Chao-Hung Kuo, I-Chen Wu, Sophie S. W. Wang, Angela Chen, Wen-Chung Hung, David Y. Graham* - - 1 - Clin Gastroenterol Hepatol - CLIN GASTROENTEROL H 2010;8(1):36-41
(IF: 6.068, Journal Ranking: 8, Number of Journals of this Field: 55, Ranking: 14.55%)

34

P-selectin¾É­P¤§¦å¤pªO¾®¶°©M­ä¤`¥i¯à¸ÑÄÀ«Õªù±ìµß·P¬V¤Þ°_¤§¦å¤pªO´î¤Ö¯g
¸­¨q¯u, Tsai S,§dµn±j,§d¬F¼Ý,¼B¤j´¼,³¯­Y·æ* - - 1 - Blood - HEMATOLOGY 2010 115¨÷(21´Á):4247-4253­¶
(IF: 1.425, »â°ì±Æ¦W: 47, »â°ì´Á¥Z¼Æ: 62, »â°ì±Æ¦W: 75.81%)

P-selectin dependent platelet aggregation and apoptosis may explain the decrease in platelet count during H. pylori infection.
Yeh JJ, Tsai S, Wu DC, Wu JY, Liu TC, Chen A*. - - 1 - Blood - HEMATOLOGY 2010;115(21):4247-4253
(IF: 1.425, Journal Ranking: 47, Number of Journals of this Field: 62, Ranking: 75.81%)

35

¥\¯à©ÊGlutathione Peroxidase 3°ò¦]¦h«¬©Ê»P¥xÆW­GÀù¯f±w¦MÀI©Ê¼W¥[¬ÛÃö
¤ý·Ó¤¸,·¨¥H«Ì,§dµn±j,¶À§ÓÞ³,§d¬F¼Ý,¨ô¦g¯è* - - 1 - Clin Chim Acta - CLIN CHIM ACTA 2010 411¨÷(19´Á):1432-6­¶
(IF: 2.535, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 28, »â°ì±Æ¦W: 17.86%)

Functional Glutathione Peroxidase 3 Polymorphisms Associated with Increased Risk of Taiwanese Patients with Gastric Cancer
Jaw-Yuan Wang ,I-Ping Yang,Deng-Chyang Wu ,Szu-wei Huang ,Jeng-Yih Wu,Suh-Hang Hank Juo* - - 1 - Clin Chim Acta - CLIN CHIM ACTA 2010;411(19):1432-6
(IF: 2.535, Journal Ranking: 5, Number of Journals of this Field: 28, Ranking: 17.86%)

36

P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection.
¸­¥¿©¾, Tsai S, §dµn±j, §d¬F¼Ý, ¼B¤j´¼, ³¯©M·æ* - - 1 - Blood - BLOOD 2010 115¨÷(21´Á):4247-53­¶
(IF: 10.555, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 61, »â°ì±Æ¦W: 3.28%)

P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection.
Yeh JJ, Tsai S, Wu DC, Wu JY, Liu TC, Chen A* - - 1 - Blood - BLOOD 2010;115(21):4247-53
(IF: 10.555, Journal Ranking: 2, Number of Journals of this Field: 61, Ranking: 3.28%)

37

Caution Regarding PCR Detection of Helicobacter pylori in Clinical or Environmental Samples
Sugimoto M, §d¬F¼Ý, Abudayyeh S, Hoffman J, Brahem H, Al-Khatib K, Yamaoka Y, Graham DY*. - - 1 - J Clin Microbiol - J CLIN MICROBIOL 2009 47¨÷(3´Á):738-4­¶
(IF: 3.945, »â°ì±Æ¦W: 18, »â°ì´Á¥Z¼Æ: 91, »â°ì±Æ¦W: 19.78%)

Caution Regarding PCR Detection of Helicobacter pylori in Clinical or Environmental Samples
Sugimoto M, Wu JY, Abudayyeh S, Hoffman J, Brahem H, Al-Khatib K, Yamaoka Y, Graham DY*. - - 1 - J Clin Microbiol - J CLIN MICROBIOL 2009;47(3):738-4
(IF: 3.945, Journal Ranking: 18, Number of Journals of this Field: 91, Ranking: 19.78%)

38

The peopling of the Pacific from a bacterial perspective.
Moodley Y, Linz B, Yamaoka Y, Windsor HM, Breurec S, §d¬F¼Ý, Maady A, Bernhöft S, Thiberge JM, Phuanukoonnon S, Jobb G, Siba P, Graham DY, Marshall BJ, Achtman M*. - - 1 - Science - SCIENCE 2009 323¨÷(5913´Á):527-30­¶
(IF: 28.103, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 42, »â°ì±Æ¦W: 4.76%)

The peopling of the Pacific from a bacterial perspective.
Moodley Y, Linz B, Yamaoka Y, Windsor HM, Breurec S, Wu JY, Maady A, Bernhöft S, Thiberge JM, Phuanukoonnon S, Jobb G, Siba P, Graham DY, Marshall BJ, Achtman M*. - - 1 - Science - SCIENCE 2009;323(5913):527-30
(IF: 28.103, Journal Ranking: 2, Number of Journals of this Field: 42, Ranking: 4.76%)

39

RIFAMPIN¬ÛÃö¤§°°½¤©Ê¸zª¢
³¯±¬ªN,¿c¬f¼Ù,ªL½«¦p,ªL«T¯§,§d¬F¼Ý,³¯«Û¦°* - - 1 - AM J MED SCI - AM J MED SCI 2009 338¨÷(2´Á):156-8­¶
(IF: 1.36, »â°ì±Æ¦W: 58, »â°ì´Á¥Z¼Æ: 107, »â°ì±Æ¦W: 54.21%)

Rifampin-associated pseudomembranous colitis.
TUN-CHIEH CHEN, PO-LIANG LU, WEI-RU LIN, CHUN-YU LIN, JENG-YIH WU, YEN-HSU CHEN* - - 1 - AM J MED SCI - AM J MED SCI 2009;338(2):156-8
(IF: 1.36, Journal Ranking: 58, Number of Journals of this Field: 107, Ranking: 54.21%)

40

²Ä¤G´Á»P²Ä¤T´Áµ²ª½¸zÀù¯f±w®Úªv©Ê¤Á°£¤â³N¦­´Á´_µo¤§¹w´ú¦]¤l
½²²»Åï,¦¶¥ú¿³,¶À¤Í©M,Ĭ¨|¬F,§d¬F¼Ý,³¢¬L§»,³¯¬L¤å,¤ý·Ó¤¸* - - 1 - JOURNAL OF SURGICAL ONCOLOGY - J SURG ONCOL 2009 100¨÷(8´Á):736-743­¶
(IF: 2.478, »â°ì±Æ¦W: 33, »â°ì´Á¥Z¼Æ: 148, »â°ì±Æ¦W: 22.30%)

Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection
HSIANG-LIN TSAI,KOUNG-SHING CHU,YU-HO HUANG,YU-CHUNG SU,JENG-YIH WU,CHAO-HUNG KUO,CHAO-WEN CHEN,JAW-YUAN WANG* - - 1 - JOURNAL OF SURGICAL ONCOLOGY - J SURG ONCOL 2009;100(8):736-743
(IF: 2.478, Journal Ranking: 33, Number of Journals of this Field: 148, Ranking: 22.30%)

41

Superior mesenteric artery syndrome in a diabetic patient with acute weight loss
§d©sªN,§d©y¬Ã,§d¬F¼Ý,§dµn±j,¤ý¤å©ú* - - 1 - World J Gastroenterol. - WORLD J GASTROENTERO 2009 15¨÷(47´Á):6004-6­¶
(IF: 2.081, »â°ì±Æ¦W: 32, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 58.18%)

Superior mesenteric artery syndrome in a diabetic patient with acute weight loss
Meng-Chieh Wu, I-Chen Wu, Jeng-Yih Wu, Deng-Chyang Wu, Wen-Ming Wang - - 1 - World J Gastroenterol. - WORLD J GASTROENTERO 2009;15(47):6004-6
(IF: 2.081, Journal Ranking: 32, Number of Journals of this Field: 55, Ranking: 58.18%)

42

¥HOxaliplatin/5-fluorouracil/leucovorin (FOLFOX4)§@¬°¶i¦æ´ÁªÅ¸z¸¢Àù»²§U¤Æ¾ÇªvÀø¡G¨â¯f¨Ò³ø§i
³¯¬L¤å, ¤ý¤å©ú, Ĭ¨|¥¿, §d¬F¼Ý, Á«ؾ±, ¤ý·Ó¤¸* - - 1 - Medical Principles and Practice - MED PRIN PRACT 2008 17¨÷(6´Á):496-499­¶
(IF: 0.542, »â°ì±Æ¦W: 77, »â°ì´Á¥Z¼Æ: 100, »â°ì±Æ¦W: 77.00%)

Oxaliplatin/5-fluorouracil/leucovorin (FOLFOX4) regimen as an adjuvant chemotherapy in the treatment of advanced jejunal adenocarcinoma: a report of 2 cases
Chao-Wen Chen , Wen-Ming Wang, Yu-Chung Su, Jeng-Yih Wu, Jan-Sing Hsieh, Jaw-Yuan Wang* - - 1 - Medical Principles and Practice - MED PRIN PRACT 2008;17(6):496-499
(IF: 0.542, Journal Ranking: 77, Number of Journals of this Field: 100, Ranking: 77.00%)

43

Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils.
Kudo T, Lu H, §d¬F¼Ý, Ohno T, Wu MJ, Genta RM, Graham DY, Yamaoka Y* - - 1 - GASTROENTEROLOGY - GASTROENTEROLOGY 2007 132¨÷(3´Á):1024-1038­¶
(IF: 11.673, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 2.00%)

Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils.
Kudo T, Lu H, Wu JY, Ohno T, Wu MJ, Genta RM, Graham DY, Yamaoka Y. - - 1 - GASTROENTEROLOGY - GASTROENTEROLOGY 2007;132(3):1024-1038
(IF: 11.673, Journal Ranking: 1, Number of Journals of this Field: 50, Ranking: 2.00%)

44

Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains.
Lu H, §d¬F¼Ý, Beswick EJ, Ohno T, Odenbreit S, Haas R, Reyes VE, Kita M, Graham DY, Yamaoka Y* - - 1 - JOURNAL OF BIOLOGICAL CHEMISTRY - J BIOL CHEM 2007 282¨÷(9´Á):6242-6254­¶
(IF: 5.581, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 263, »â°ì±Æ¦W: 15.21%)

Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains.
Lu H, Wu JY, Beswick EJ, Ohno T, Odenbreit S, Haas R, Reyes VE, Kita M, Graham DY, Yamaoka Y* - - 1 - JOURNAL OF BIOLOGICAL CHEMISTRY - J BIOL CHEM 2007;282(9):6242-6254
(IF: 5.581, Journal Ranking: 40, Number of Journals of this Field: 263, Ranking: 15.21%)

45

Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome
Fujimoto S, Olaniyi Ojo O, Arnqvist A, §d¬F¼Ý, Odenbreit S, Haas R, Graham DY, Yamaoka Y* - - 1 - Clin Gastroenterol Hepatol - 2007 5¨÷(1´Á):49-58­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome
Fujimoto S, Olaniyi Ojo O, Arnqvist A, Wu JY, Odenbreit S, Haas R, Graham DY, Yamaoka Y. - - 1 - Clin Gastroenterol Hepatol - 2007;5(1):49-58
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

46

Rabeprazole- versus Esomeprazole-based eradication regimens for H. pylori infection in Taiwan
§d©y¬Ã, §dµn±j, ³\ªÃ¼Ý, ¿c«Ø¦t, ¤ý»a®¦, ±i¤åºµ, ³¯§Ó¬w, ³¢´I¬Ã, §d¬F¼Ý, ¤ý¤å©ú, ¥Õ©ú©¾* - - 1 - HELICOBACTER - HELICOBACTER 2007 12¨÷(6´Á):633-7­¶
(IF: 2.423, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 46.00%)

Rabeprazole- versus Esomeprazole-based eradication regimens for H. pylori infection in Taiwan
Wu IC, Wu DC, Hsu PI, Lu CY, Wang TE, Chang WH, Chen JJ, Kuo FC, Wu JY, Wang WM, Bair MJ* - - 1 - HELICOBACTER - HELICOBACTER 2007;12(6):633-7
(IF: 2.423, Journal Ranking: 23, Number of Journals of this Field: 50, Ranking: 46.00%)

47

²Ä¤G´Á¤j¸zª½¸zÀù®Úªv©Ê¤â³N«á¦h­«¤À¤l¼Ð°O¤§¹w«á·N¸q
·Å¸q½÷,ªL绣¯ø,§dµn±j,Ĭ¨|¥¿,§d¬F¼Ý,¾G²K¿ý,±­ÀA¤å,¤ý·Ó¤¸* - - 1 - Annals of Surgery - ANN SURG 2007 246¨÷(6´Á):1040-1046­¶
(IF: 7.446, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 0.72%)

Prognostic Significance of Multiple Molecular Markers for Patients with Stage II Colorectal Cancer Undergoing Curative Resection
Yih-Huei Uen, Shiu-Ru Lin, Deng-Chyang Wu, Yu-Chung Su, Jeng-Yih Wu, Tian-Lu Cheng, Chin-Wen Chi, Jaw-Yuan Wang* - - 1 - Annals of Surgery - ANN SURG 2007;246(6):1040-1046
(IF: 7.446, Journal Ranking: 1, Number of Journals of this Field: 139, Ranking: 0.72%)

48

¥xÆW°¸µo©Ê¤j¸zª½¸zÀù¯f±w¤£¦P ¤§APC. K-ras, p53°ò¦]ªí²{«¬ºA
¤ý·Ó¤¸, Á«ؾ± , ¿c«Ø¦t, §EªÚºa , §d¬F¼Ý, ³¯ªÚ»Ê , ¶À­õ¤H, ªL绣¯ø* - - 1 - Hepato-Gastroentroenterology - HEPATO-GASTROENTEROL 2007 54¨÷(80´Á):2259-2265­¶
(IF: 0.904, »â°ì±Æ¦W: 92, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 66.19%)

The Differentially Mutational Spectra of the APC, K-ras, and p53 Genes in Sporadic Colorectal Cancers from Taiwanese Patients
Jaw-Yuan Wang , Jan-Sing Hsieh , Chien-Yu Lu , Fang-Jung Yu , Jeng-Yih Wu , Fang-Ming Chen , Che-Jen Huang , Shiu-Ru Lin* - - 1 - Hepato-Gastroentroenterology - HEPATO-GASTROENTEROL 2007;54(80):2259-2265
(IF: 0.904, Journal Ranking: 92, Number of Journals of this Field: 139, Ranking: 66.19%)

49

½¦Ån¤ºµøÃè©ó¤p¸z¯e¯fªºÀ³¥Î¡Ð28¦ì¯f¤Hªº¤ÀªR
¼B©s«a,§E¤èºa,§d¬F¼Ý,§d©y¬Ã,¤ý·Ó¤¸,Á«ؾ±,¤ý¤å©ú,§dµn±j* - - 0 - Kaohsiung J Med Sci. - 2006 22¨÷(9´Á):425-431­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Capsule endoscopy (CE) is used to diagnose small intestine disease. Many studies have shown a better lesion detection rate in obscure gastrointestinal (GI) bleeding than with other surveyed techniques. Our study investigates the diagnostic value of CE in patients with suspicious small intestine diseases. Between October 2004 and January 2006, patients who had suspected small intestine disease underwent CE in Kaohsiung Medical University Hospital. Presenting symptoms included obscure GI bleeding,
Liu MK, Yu FJ, Wu JY, Wu IC, Wang JY, Hsieh JS, Wang WM, Wu DC* - - 0 - Kaohsiung J Med Sci. - 2006;22(9):425-431
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

50

Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression.
§d¬F¼Ý, Lu H, Sun Y, Graham DY, Cheung HS, Yamaoka Y*. - - 0 - Cancer Res. - CANCER RES 2006 66¨÷(10´Á):5111-20­¶
(IF: 7.616, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 123, »â°ì±Æ¦W: 8.94%)

Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression.
Wu JY, Lu H, Sun Y, Graham DY, Cheung HS, Yamaoka Y*. - - 0 - Cancer Res. - CANCER RES 2006;66(10):5111-20
(IF: 7.616, Journal Ranking: 11, Number of Journals of this Field: 123, Ranking: 8.94%)

51

Randomized comparison of two rescue therapies for Helicobacter pylori infection.
§dµn±j,³\ªÃ¼Ý,³¯©M·æ,¾¤°ê¬x,½²®p°¶,§d«T¤¤,ùÀAªe,§d¬F¼Ý,§d©y¬Ã,¤ý¤å©ú,´¿·uµØ* - - 1 - Eur J Clin Invest. - EUR J CLIN INVEST 2006 36¨÷(11´Á):803-9­¶
(IF: 2.684, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 105, »â°ì±Æ¦W: 19.05%)

Randomized comparison of two rescue therapies for Helicobacter pylori infection.
Wu DC, Hsu PI, Chen A, Lai KH, Tsay FW, Wu CJ, Lo GH, Wu JY, Wu IC, Wang WM, Tseng HH*. - - 1 - Eur J Clin Invest. - EUR J CLIN INVEST 2006;36(11):803-9
(IF: 2.684, Journal Ranking: 20, Number of Journals of this Field: 105, Ranking: 19.05%)

52

Tetracycline-Resistant Clinical Helicobacter pylori Isolates with and without Mutations in 16S rRNA-Encoding Genes
§d¬F¼Ý, Kim JJ, Reddy R, ¤ý¤å©ú, Graham DY, Kwon DH* - - 1 - ANTIMICROBIAL AGENTS AND CHEMOTHERAPY - ANTIMICROB AGENTS CH 2005 49¨÷(2´Á):578-583­¶
(IF: 4.379, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 193, »â°ì±Æ¦W: 12.95%)

Tetracycline-Resistant Clinical Helicobacter pylori Isolates with and without Mutations in 16S rRNA-Encoding Genes
Wu JY, Kim JJ, Reddy R, Wang WM, Graham DY, Kwon DH* - - 1 - ANTIMICROBIAL AGENTS AND CHEMOTHERAPY - ANTIMICROB AGENTS CH 2005;49(2):578-583
(IF: 4.379, Journal Ranking: 25, Number of Journals of this Field: 193, Ranking: 12.95%)

53

Evaluation of urine ELISA test for detecting Helicobacter pylori infection in Taiwan: A prospective study
³¢´I¬Ã, ¤ý¸t¶², §d©y¬Ã, §E¤èºa, ·¨²W³Ç, §d¬F¼Ý, ¤ý¤å©ú, §dµn±j - - 0 - World J Gastroenterol - 2005 11¨÷(35´Á):5545-5548­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Evaluation of urine ELISA test for detecting Helicobacter pylori infection in Taiwan: A prospective study
Kuo FC, Wang SW, Wu IC, Yu FJ, Yang YC, Wu JY, Wang WM, Wu DC - - 0 - World J Gastroenterol - 2005;11(35):5545-5548
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

54

Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype
Vilaichone RK, Mahachai V, Tumwasorn S, §d¬F¼Ý, Graham DY, Yamaoka Y* - - 1 - SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY - SCAND J GASTROENTERO 2005 40¨÷(5´Á):530-539­¶
(IF: 1.79, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 52.17%)

Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype
Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y* - - 1 - SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY - SCAND J GASTROENTERO 2005;40(5):530-539
(IF: 1.79, Journal Ranking: 24, Number of Journals of this Field: 46, Ranking: 52.17%)

55

Comparison of 13C-urea breath test values in gastric cancer, peptic ulcer and gastritis
´¿ªø¦w, §d¬F¼Ý, ¼ï¥Ã¥Í, ³¢¬L§», ¿c«Ø¦t, Ĭ¨|¥¿, §dµn±j, ´^¹D¶¯, ¸â©÷©ú, ¤ý¤å©ú* - - 1 - HEPATO-GASTROENTEROL - HEPATO-GASTROENTEROL 2005 52¨÷(65´Á):1636-1640­¶
(IF: 0.699, »â°ì±Æ¦W: 99, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 71.22%)

Comparison of 13C-urea breath test values in gastric cancer, peptic ulcer and gastritis
Tseng CA, Wu JY, Pan YS, Yu FJ, Kuo CH, Lu CY, Su YC, Wu DC, Perng DS, Jan CM, Wang WM* - - 1 - HEPATO-GASTROENTEROL - HEPATO-GASTROENTEROL 2005;52(65):1636-1640
(IF: 0.699, Journal Ranking: 99, Number of Journals of this Field: 139, Ranking: 71.22%)

56

Capsaicin-induced cell death in a human gastric adenocarcinoma cell line.
ù©É­ë, ·¨²W³Ç, §d©y¬Ã, ³¢´I¬Ã, ¼B´Ñ»Ê, ¨L©þ½n, ³¢¬L§», §d¬F¼Ý, §dµn±j* - - 0 - World J Gastroenterol - 2005 11¨÷(40´Á):6254-7­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Capsaicin-induced cell death in a human gastric adenocarcinoma cell line.
Lo YC, Yang YC, Wu IC, Kuo FC, Liu CM, Wang HW, Kuo CH, Wu JY, Wu DC* - - 0 - World J Gastroenterol - 2005;11(40):6254-7
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

57

Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori.
Lu H, §d¬F¼Ý, Kudo T, Ohno T, Graham DY, Yamaoka Y* - - 1 - MOLECULAR BIOLOGY OF THE CELL - MOL BIOL CELL 2005 16¨÷(10´Á):4954-4966­¶
(IF: 6.52, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 153, »â°ì±Æ¦W: 15.03%)

Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori.
Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y* - - 1 - MOLECULAR BIOLOGY OF THE CELL - MOL BIOL CELL 2005;16(10):4954-4966
(IF: 6.52, Journal Ranking: 23, Number of Journals of this Field: 153, Ranking: 15.03%)

58

Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori.
Kudo T, Lu H, §d¬F¼Ý, Graham DY, Casola A, Yamaoka Y* - - 1 - INFECTION AND IMMUNITY - INFECT IMMUN 2005 73¨÷(11´Á):7602-7612­¶
(IF: 3.933, »â°ì±Æ¦W: 22, »â°ì´Á¥Z¼Æ: 115, »â°ì±Æ¦W: 19.13%)

Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori.
Kudo T, Lu H, Wu JY, Graham DY, Casola A, Yamaoka Y* - - 1 - INFECTION AND IMMUNITY - INFECT IMMUN 2005;73(11):7602-7612
(IF: 3.933, Journal Ranking: 22, Number of Journals of this Field: 115, Ranking: 19.13%)

59

Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads
Vilaichone RK, Mahachai V, Tumwasorn S, §d¬F¼Ý, Graham DY, Yamaoka Y* - - 1 - Helicobacter - 2004 9¨÷(5´Á):453-9­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads
Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y* - - 1 - Helicobacter - 2004;9(5):453-9
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

 Project

NO
YEAR ¡X Source ¡X No ¡X Type
Project Name
Duration
1
112 ¡X KK °ª¬ì¤j°ªÂå²£¾Ç¦X§@¸É§U ¡X   ¡X 3 ²£¾Ç¦X§@
¹B¥Î¤H¤u´¼¼z¹ê²{¯f¾ú¥D¶Dµ²ºc¤Æ»P¬Ý¶E¬ì§O±ÀÂË( )
2023/11/01 ~ 2024/12/31
2
110 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST110-2314-B-037-098 ¡X 1 ­Ó¤H«¬
®Ú°£«ÕªùÁ³±Û±ìµß¥H½Õ¸`²Ó­M¦Û¾½¶i¦Ó§ïµ½2«¬¿}§¿¯f¤Hªº¿}±±¨î¨ÖÆ[¹îÅé­«ÅܤƻP¸z¹DµßÂO§ïÅܤέ°§C¯Ø®q¯À©è§Ü¤§¬ã¨s( )
2021/08/01 ~ 2023/01/31
3
103 ¡X NK °ªÂå-¤¤¤s¦X§@­pµe ¡X NSYSUKMU103-P018 ¡X 1 ­Ó¤H«¬
¦å¤pªO¦b«ÕªùÁ³±Û±ìµß·P¬V®É©Ò¾á¥ô¥ý¤Ñ§K¬Ì¤§¨¤¦â(The role of platelets in innate immunity induced by Helicobacter pylori infection)
2014/01/01 ~ 2014/12/31
4
102 ¡X NK °ªÂå-¤¤¤s¦X§@­pµe ¡X NSYSUKMU102-P020 ¡X 1 ­Ó¤H«¬
¦å¤pªO¦b«ÕªùÁ³±Û±ìµß·P¬V»¤µo§]¾½²Ó­M¬¡¤Æ¤§¨¤¦â(The role of platelets in macrophage activation induced by Helicobacter pylori infection)
2013/01/01 ~ 2013/12/31
5
101 ¡X NK °ªÂå-¤¤¤s¦X§@­pµe ¡X NSYSUKMU101-032 ¡X 1 ­Ó¤H«¬
±´°Q¦å¤pªOªí­±§Ü­ì¦b«ÕªùÁ³±Û±ìµß¤Þ°_ªº¦å¤pªO­ä¤`¤§¨¤¦â(The role of platelet surface proteins in Hp induced platelet apoptosis)
2012/01/01 ~ 2012/12/31
6
100 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC100-2314-B-037-040 ¡X 1 ­Ó¤H«¬
§Q¥ÎÄa¯B³J¥Õ·L°}¦C¤ÀªR§Þ³N¥­¥x,«Ø¥ßÁ{§É­GÀù³J¥Õ¤À¤l½èÃЫü¯¾¤Î°ª±M¤@©Ê­GÀù³J¥Õ¥Íª«¼Ð°O¤§Å²©w,¨ÃÅçÃÒÁ{§É­GÀù°ª¦MÀI¸s¤§±M¤@©Ê»P±Ó·P©Ê( )
2011/08/01 ~ 2012/12/31
7
099 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC97-2314-B-037-047-MY3 ¡X 1 ­Ó¤H«¬
¤£¦P°ò¦]«¬«ÕªùÁ³±Û±ìµß¹ï¦åºÞ¤º¥Ö¥Íªø¦]¤l(VEGF)¤Î¯Ê®ñ»¤µo¦]¤l(HIF-1£\)ÂàĶ½Õ±±¤§¬ã¨s»PÀ³¥Î(3/3)( )
2010/08/01 ~ 2011/07/31
8
098 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC97-2314-B-037-047-MY3 ¡X 1 ­Ó¤H«¬
¤£¦P°ò¦]«¬«ÕªùÁ³±Û±ìµß¹ï¦åºÞ¤º¥Ö¥Íªø¦]¤l(VEGF)¤Î¯Ê®ñ»¤µo¦]¤l(HIF-1£\)ÂàĶ½Õ±±¤§¬ã¨s»PÀ³¥Î(2/3)( )
2009/08/01 ~ 2011/07/31
9
097 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC97-2314-B-037-047-MY3 ¡X 1 ­Ó¤H«¬
¤£¦P°ò¦]«¬«ÕªùÁ³±Û±ìµß¹ï¦åºÞ¤º¥Ö¥Íªø¦]¤l(VEGF)¤Î¯Ê®ñ»¤µo¦]¤l(HIF-1£\)ÂàĶ½Õ±±¤§¬ã¨s»PÀ³¥Î(1/3)( )
2008/08/01 ~ 2011/07/31
10
097 ¡X Q ·s¸u±Ð®v­pµe(®Õ¤º) ¡X KMU-Q098033 ¡X  
§Q¥Î«ÕªùÁ³±Û±ìµß¬ã¨s¥xÆW­ì¦í¥Á¦UºØ±Ú¤Î«n®q»y¨tºØ±Ú¶¡¤§Ãö«Y¨Ã±´°Q¨ä»P¯e¯f¤§¬ÛÃö©Ê( )
2009/01/01 ~ 2009/12/31
11
095 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC95-2314-B-037-018- ¡X 1 ­Ó¤H«¬
«ÕªùÁ³±Û±ìµß¹ï²ÄI«¬¶¡½è³J¥Õ–¡ªí¹FÂà¿ý½Õ±±¾÷Âध¬ã¨s( )
2006/08/01 ~ 2007/07/31
12
093 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC93-2314-B-037-080- ¡X 1 ­Ó¤H«¬
«ÕªùÁ³±Û±ìµß¥~½¤³J¥Õ¤Î¨ä°ò¦]»PªþµÛ²Ó­M¯à¤O,²Ó­M¤¶½èªº¤Þ¾É¤ÎCagA³J¥ÕÁC»Ä¤Æ¶¡ªºÃö«Y( )
2004/08/01 ~ 2005/07/31

 Patent